ATC | B/G | Ingredients | code | Registration Nb | Name | Dosage | Presentation | Form | Route | Agent | Laboratory | Country | Price | Pharmacist Margin | Stratum | Responsible Party Name | Responsible Party Country | Exch_date | %SUBSIDY |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
L01XX44 | BioTech | Aflibercept - 200mg/8ml | 7638 | 186626/13 | ZALTRAP | 200mg/8ml | 1 | Injectable concentrate for solution | Infusion | Mersaco | Sanofi Aventis Deutschland GmbH | Germany | 63,807,499 L.L | 10.71 | E1 | Sanofi Aventis Groupe | France | 2/5/2024 | 0 |
ATC | B/G | Ingredients | code | Registration Nb | Name | Dosage | Presentation | Form | Route | Agent | Laboratory | Country | Price | Pharmacist Margin | Stratum | Responsible Party Name | Responsible Party Country | Exch_date | %SUBSIDY |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
L01XX44 | BioTech | Aflibercept - 200mg/8ml | 11807 | 109223/1 | ZALTRAP | 200mg/8ml | 1 | Injectable concentrate for solution | Infusion | Mersaco | Sanofi Aventis Deutschland GmbH | Germany | 63,807,499 L.L | 10.71 | E1 | Sanofi Winthrop Industrie | France | 2/5/2024 | 0 |